Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIIOngoingD-0219-2026

Drug recall · December 17, 2025

Varenicline Tablets recall

Why: Sub potent drug: during the 9-month stability test conducted, the assay value for the affected lot was below specification limit.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Varenicline Tablets, 1mg, 56 Tablets, Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC 43598-908-56

Lots / codes

Lot # F2400244, Exp Date: 10/31/2026

Quantity
4800 54-count bottles
Company
Dr. Reddy's Laboratories, Inc., Princeton, NJ
Distribution
Distributed Nationwide
Initiated
November 11, 2025 · Voluntary: Firm initiated
Classified
December 5, 2025
Reported
December 17, 2025
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Varenicline

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.